According to a recent LinkedIn post from Infinity Bio Inc, the company is actively participating in IMMUNOLOGY2026 in Boston, highlighting scientific and networking activities involving its team members. The post notes that Katy Shaw-Saliba, Ph.D., is engaging in a biotech professions networking session and presenting a poster on decoding the antibody reactome at scale using novel antigen display technology.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post also points to a presence on the exhibition floor, with team member Jean-Philippe Laine available at Booth 418 throughout the day. For investors, this visibility at a major immunology conference may indicate efforts to showcase Infinity Bio’s antibody reactomics capabilities, attract talent, and deepen relationships with academic and industry stakeholders, potentially supporting longer-term partnership and pipeline development opportunities.